Ramesh Krishnan, CEO, India operations, Parkway Pantai, on varied strategies that led to re-positioning of Global Hospitals and Continental Hospitals.
Parkway Pantai Limited, a subsidiary of Malaysia’s IHH Berhad Group, has captured a significant pie of the India healthcare market with two back-to back acquisitions in 2015. Asia’s largest healthcare player, Parkway, scooped up 51% stake in Hyderabad’s Continental Hospitals in March, and followed it up with 74% stake in Hyderabad’s Global Hospitals.
The group’s other investments through 50% JV route include the under construction Parkway Khubchandani Hospital in Mumbai, Apollo Gleneagles in Kolkata as well as a PET Centre in Hyderabad in association with Apollo. Parkway also has its indirect presence in India through IHH, which holds 10.85% stake in Apollo Hospitals Enterprises Limited.
Parkway’s current growth strategy in India is revolved around realigning Global and Continental Hospitals as per global standards as well as fortifying the group’s presence in cities where it has its footprint.
Parkway’s expansion plans in India gained momentum, after you joined the group as the head of Middle East and South Asia region. What growth strategy you had in mind, when Parkway set out to acquire projects in India?
Post the IPO, around five years back, Parkway chalked out an array of imperatives that defined its roadmap for India. The Indian healthcare market was poised for rapid growth and Parkway zeroed in on India as a core market in Asia.
The first imperative was not to tread on the Greenfield path. This was based on our experience of inordinate delays and setbacks that impair Greenfield projects in India. The decision was also buoyed by the fact that acquisitions would help us hit the market faster and would be a better vehicle for growth. And, in acquisitions, we decided to forge deals with hold majority stake.
この記事は Healthcare Radius の September 2016 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は Healthcare Radius の September 2016 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン
KIMSHEALTH launches electrophysiology lab with 3D mapping
'ENSITE X' is the first of its kind in Kerala and the third in India enabling precise identification, mapping, and targeting the abnormal electrical activities in the heart.
Molbio boosts Goa's healthcare system with CSR initiatives
The company has donated four state-of-the-art Advanced Life Support (ALS) ambulances and two hearse vans for National Highway emergencies
USV introduces affordable heart failure medication
This cost-effective option addresses the rising cases of heart failure in India, offering lifesaving care to millions of patients who need it the most.
City Imaging & Clinical Labs to expand services to 50 hospitals
The company is currently associated with 10 hospitals, providing comprehensive lab management services, including 24/7 in-house phlebotomy and lab testing.
Oncare raises $1 million in seed funding, to set up 10 units
Oncare has raised $1 million in a seed funding round led by Huddle Ventures. It plans to deploy the raised capital to expand its operations to 10 new centers.
Nutrabay forays into Ayurvedic supplements market with Shilajit
Nutrabay's aims at gaining market share from the existing ayurveda supplements market with a distinctive product proposition and education about the benefits of Shilajit.
INDIA'S PREPAREDNESS ON HEALTHCARE-ASSOCIATED INFECTIONS: A GROWING FOCUS ON PATIENT SAFETY
The country's diverse healthcare landscape necessitates a flexible and multifaceted approach to infection control that can be adapted to various settings and resource levels.
TRANSFORMING CARDIAC SURGERY: HOW AI IS REVOLUTIONIZING PATIENT CARE AND OUTCOMES
Dr. Swarup Swaraj Pal shared his insights on the current state and future prospects of AI in cardiac procedures.
BEYOND THE LAB: THE CRITICAL ROLE OF LOGISTICS IN INDIA'S PHARMACEUTICAL INDUSTRY
As India continues to expand its role in the global pharmaceutical market, the importance of a robust, reliable, and innovative logistics infrastructure cannot be overstated.
LIFESTYLE DISEASES IN CHILDREN: A WAKE-UP CALL FOR A HEALTHIER GENERATION
In today's fast-paced world, children face an unexpected enemy: lifestyle diseases. Conditions like obesity, Type 2 diabetes, and hypertension are now affecting our youth. What's causing this shift, and how can we combat it?
